Regenxbio Stock Discussion

Investors' pessimism about the company's revenue prospects may be causing the low P/S ratio. The company's forecast growth is lower than the wider industry, which could be contributing to the depressed P/S. It's hard to see the share price rising strongly in the near future given these circumstances.

Despite REGENXBIO's revenue growth, its significant share price drop over the past five years suggests possible over-hype. The company's poor performance over the past year, even as the market gained, could be a warning for long-term investors.